| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/19/2002 | CN1354792A Biosynthesis of foreign proteins using transformed microalgae |
| 06/19/2002 | CN1354788A Cyclic peptides |
| 06/19/2002 | CN1354787A Process for purifying human papillomavirus virus-like particles |
| 06/19/2002 | CN1354757A Antifucoidan polysaccharide antibody |
| 06/19/2002 | CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/19/2002 | CN1354187A Hen egg yolk antibody for resisting pyloric helicobacterium cytotoxin, its preparation and application |
| 06/18/2002 | US6407216 Vertebrate smoothened antibodies |
| 06/18/2002 | US6407214 Engineering human antibodies |
| 06/18/2002 | US6407213 Method for making humanized antibodies |
| 06/18/2002 | US6406911 Recombitant cells with reporter sequence for reporter gene and heterologous sequence which codes cd4 or other cell surface receptors regulated by a protein specific to hiv |
| 06/18/2002 | US6406910 Splicing phenotypes for making nucleic acid |
| 06/18/2002 | US6406909 Soybean protein hydrolysate, yeast extract and wheat protein hydrolysate |
| 06/18/2002 | US6406908 Vanilloid receptor |
| 06/18/2002 | US6406898 Recombinant protein with pantolactone activity |
| 06/18/2002 | US6406871 Method for detecting ligand binding to G protein coupled receptors |
| 06/18/2002 | US6406865 Method of inhibiting interaction of cells bearing CCR2 by Anti-CCR2 amino-terminal domain antibodies |
| 06/18/2002 | US6406841 Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides |
| 06/18/2002 | US6406700 Antigrowth agents for cancer, heat shock proteins bonding to proteins, complexes |
| 06/18/2002 | US6406694 Anti-CCR2 antibodies |
| 06/18/2002 | CA2185098C Fk506 binding protein gene |
| 06/18/2002 | CA2098819C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions |
| 06/18/2002 | CA2025566C Method for the determination of pathogenic listeria bacteria |
| 06/13/2002 | WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha |
| 06/13/2002 | WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | WO2002046455A2 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use |
| 06/13/2002 | WO2002046437A2 Methods and compositions for highly efficient production of heterologous proteins in yeast |
| 06/13/2002 | WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | WO2002046419A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 06/13/2002 | WO2002046418A2 Lipid-associated molecules |
| 06/13/2002 | WO2002046417A2 Adipocyte complement related protein zacrp3x2 |
| 06/13/2002 | WO2002046411A2 Intestinal proteins |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046407A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | WO2002046406A2 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof |
| 06/13/2002 | WO2002046404A2 Schizophrenia-related voltage-gated ion channel gene and protein |
| 06/13/2002 | WO2002046395A1 C-terminal modified protein and process for producing the same, modifying agent and translation template to be used in produfing c-terminal modified protein, and method of detecting protein interaction with the use of c-termial modified protein |
| 06/13/2002 | WO2002046386A2 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 06/13/2002 | WO2002046385A2 Enzymes |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
| 06/13/2002 | WO2002046383A2 Protein modification and maintenance molecules |
| 06/13/2002 | WO2002046364A2 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 06/13/2002 | WO2002046237A2 Humanized antibodies that recognize beta amyloid peptide |
| 06/13/2002 | WO2002046233A1 Method for preparing a human monoclonal antibody, fragments thereof or antibodies comprising such fragments, resulting antibodies and use thereof |
| 06/13/2002 | WO2002046230A2 G-protein coupled receptors |
| 06/13/2002 | WO2002046227A2 Glp-1 fusion proteins |
| 06/13/2002 | WO2002046226A2 Trefoil factor 2 (tff2) peptides with moiety attached to asn15 |
| 06/13/2002 | WO2002046224A2 Compositions and methods relating to lung specific genes and proteins |
| 06/13/2002 | WO2002046216A2 Human sprouty-4 polypeptide |
| 06/13/2002 | WO2002046212A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/13/2002 | WO2002046210A1 Method for preparing tryptophan rich peptides |
| 06/13/2002 | WO2002046208A2 Method of producing biospecific molecules by protein trans-splicing |
| 06/13/2002 | WO2002046193A2 Heterocyclic ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046192A2 Thioether substituted imidazoquinolines |
| 06/13/2002 | WO2002046191A2 Urea substituted imidazoquinoline ethers |
| 06/13/2002 | WO2002046190A2 Sulfonamido ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046189A2 Aryl ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046188A2 Amido ether substituted imidazoquinolines |
| 06/13/2002 | WO2002045524A2 Prolyl endoprotease from aspergillus niger |
| 06/13/2002 | WO2002045523A2 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 06/13/2002 | WO2002028419A3 Chemokine mutants in the treatment of multiple sclerosis |
| 06/13/2002 | WO2002022848A3 Compositions comprising mixtures of human cytokines and methods of producing the same |
| 06/13/2002 | WO2002020038A3 Method for down-regulating ige |
| 06/13/2002 | WO2002012339A3 Sequences for integrin alpha-8 |
| 06/13/2002 | WO2002004617A3 Novel cacao endoproteinases and their use in the production of cocoa flavour |
| 06/13/2002 | WO2002004495A3 Streptococcus pyogenes antigen |
| 06/13/2002 | WO2001096377A3 Vaccine for congenital tremors in pigs |
| 06/13/2002 | WO2001094415A3 Nuclear hormone receptor |
| 06/13/2002 | WO2001087981A3 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |
| 06/13/2002 | WO2001083785A3 Regulated antigen delivery system (rads) involving bacteria |
| 06/13/2002 | WO2001079289A3 Human interferon, zinf2 |
| 06/13/2002 | WO2001064889A3 Tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 06/13/2002 | WO2001044300A3 Brain specific binding members |
| 06/13/2002 | WO2001029256A3 Cephalic pain susceptibility marker |
| 06/13/2002 | WO2000077262A9 Synthetic ligation reassembly in directed evolution |
| 06/13/2002 | US20020073447 Acquired resistance genes and uses thereof |
| 06/13/2002 | US20020072596 Nucleotide sequences coding transrerrins; for use in the treatment of nervous system., blood abbd anemia, heme biosynthesis disorders |
| 06/13/2002 | US20020072595 Nucleic acid for use in kits for detection of preferential bacterial infection |
| 06/13/2002 | US20020072497 Novel DNA and recombinant production of novel polypeptides |
| 06/13/2002 | US20020072496 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072494 Angiogenesis inhibitor, K1-5 (protease-activated kringles 1-5) genetically engineered so it can be secreted from cells in which it is expressed; contains a secretory signal peptide and a pre-activation peptide derived from plasminogen |
| 06/13/2002 | US20020072488 Amino acid sequences of human transporter peptides and proteins that are related to the sugar transporter subfamily; identifying modulators of the transporter peptides |
| 06/13/2002 | US20020072120 Helper viruses for the preparation of recombinant viral vectors |
| 06/13/2002 | US20020072117 Human feeder cells that support proliferation of undifferentiated pluripotent stem cells |
| 06/13/2002 | US20020072107 Human osteoclast derived cathepsin |
| 06/13/2002 | US20020072101 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 06/13/2002 | US20020072093 Novel leader peptides for enhancing secretion of recombinant protein from a host cell |
| 06/13/2002 | US20020072092 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072090 Hr-1 receptor |
| 06/13/2002 | US20020072088 Monitoring protein associations and activity; obtain cells, measuring expression of reporter genes, adjustment in expression indicates modulatory activity |
| 06/13/2002 | US20020072080 Immunological materials and methods for detecting dihydropyrimidine dehydrogenase |
| 06/13/2002 | US20020072067 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/13/2002 | US20020072066 Human osteoporosis gene |
| 06/13/2002 | US20020072064 Detecting polymers and polymer fragments |
| 06/13/2002 | DE10059336A1 Herstellung von rekombinantem BMP-2 Production of recombinant BMP-2 |
| 06/13/2002 | CA2716959A1 Glp-1 fusion proteins |
| 06/13/2002 | CA2436984A1 Urea substituted imidazoquinoline ethers |
| 06/13/2002 | CA2436983A1 Sulfonamido ether substituted imidazoquinolines |
| 06/13/2002 | CA2436732A1 Protein modification and maintenance molecules |
| 06/13/2002 | CA2431203A1 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | CA2431202A1 Human sprouty-4 polypeptide |